Ebola

The World Health Organisation (WHO) has warned West Africa may face up to 10,000 new Ebola cases per week within two months, due to the increasing number of patients.

With a reported death rate of 70%, the Ebola death toll has reached 4,447 out of the reported 8,900 cases in West Africa. The majority of victims are from the three hardest-hit nations: Sierra Leone, Liberia and Guinea.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

WHO assistant director general Dr Bruce Aylward was quoted by Associated Press saying that the UN health agency was still focused on trying to get sick people isolated and provide treatment as early as possible.

Aylward also added that if the world’s response to the Ebola crisis is not improved within 60 days, ‘a lot more people will die’ and health workers will be stretched even further.

Ivory Coast, Mali and Guinea-Bissau are some of the nations at high risk of importing the disease, noted Aylward.

The International Atomic Energy Agency (IAEA) announced plans to provide specialised diagnostic equipment to help Sierra Leone in its efforts to combat an ongoing Ebola Virus Disease (EVD) outbreak.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

IAEA will provide diagnostic technology known as Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) to diagnose the disease quickly.

IAEA director general Yukiya Amano said: "Transfer of nuclear-related technologies is a key part of the agency’s work, and we have cooperated with member states for years to develop and strengthen their capacity to use this nuclear-derived technology."


Image: Ebola virus virion. Photo: courtesy of CDC/Cynthia Goldsmith.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact